It is absolutely no coincidence that we have been working to shift the local offering away from a focus on some of our more conventional treatments…
In Conversation
In concrete terms, a diabetic patient for example, can go to his pharmacy with his prescription, get the necessary drugs for 3 months of treatment worth…
We would like to reach 100 percent local production by 2020
To sustain the system, the current dynamics will have to change
The economic benefits of this industry are a secondary priority; quality care and service are Turkey's first concern.
Eczacıbaşı partners with different stakeholders across all our areas of operations. This is our business model and it has always been successful for us, but also…
We were an early mover in embracing the concept of local production way before localization became enshrined as a core government priority
Ece Kaşıkçı, General Manager, Bristol-Myers Squibb (BMS) Turkey, outlines how BMS’ groundbreaking immuno-oncology therapy has proudly become the first product of its kind to be registered…
With the 2014-2019 Cancer Plan, we answered every tender call, won a number of them, and honored the corresponding contracts.
I have worked across Africa and the Middle East but am yet to encounter a country like Algeria where the government is so committed to healthcare
Our first product should be manufactured in January 2019. I am confident that we can gain a substantial market share
Production has already started in our new facility, which is one of the biggest biological production sites in Turkey, located in Ankara.
